Mire tanítanak a vérnyomáscsökkentokkel végzett újabb renoprotektív vizsgálatok?

Translated title of the contribution: Lessons from the novel renoprotective studies made by antihypertensive drugs

László Bajnok, I. Belgyógyászati Klinika

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

From the evaluated ONTARGET, ALTITUDE, ACCOMPLISH, ROADMAP, and ACCORD-BP studies a conclusion can be drawn that though microalbuminuria/proteinuria is a strong epidemiological biomarker, in interventional studies it is not necessarily a reliable surrogate endpoint as actual renal function may change in an opposite way. Namely, some therapeutic measures improving microalbuminuria/proteinuria may actually worsen renal function. In case of procedures such as blood pressure lowering or measure of RAS blockade an optimum point on a J-curve may exist. Orv. Hetil., 2013, 154, 243-247.

Original languageHungarian
Pages (from-to)243-247
Number of pages5
JournalOrvosi Hetilap
Volume154
Issue number7
DOIs
Publication statusPublished - 2013

Fingerprint

Proteinuria
Antihypertensive Agents
Biomarkers
Kidney
Blood Pressure
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mire tanítanak a vérnyomáscsökkentokkel végzett újabb renoprotektív vizsgálatok? / Bajnok, László; Klinika, I. Belgyógyászati.

In: Orvosi Hetilap, Vol. 154, No. 7, 2013, p. 243-247.

Research output: Contribution to journalArticle

Bajnok, László ; Klinika, I. Belgyógyászati. / Mire tanítanak a vérnyomáscsökkentokkel végzett újabb renoprotektív vizsgálatok?. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 7. pp. 243-247.
@article{e4254077149d4f4680e76f5640a3ae87,
title = "Mire tan{\'i}tanak a v{\'e}rnyom{\'a}scs{\"o}kkentokkel v{\'e}gzett {\'u}jabb renoprotekt{\'i}v vizsg{\'a}latok?",
abstract = "From the evaluated ONTARGET, ALTITUDE, ACCOMPLISH, ROADMAP, and ACCORD-BP studies a conclusion can be drawn that though microalbuminuria/proteinuria is a strong epidemiological biomarker, in interventional studies it is not necessarily a reliable surrogate endpoint as actual renal function may change in an opposite way. Namely, some therapeutic measures improving microalbuminuria/proteinuria may actually worsen renal function. In case of procedures such as blood pressure lowering or measure of RAS blockade an optimum point on a J-curve may exist. Orv. Hetil., 2013, 154, 243-247.",
keywords = "blood pressure lowering, J-curve, proteinuria, RAS blockade, renoprotection",
author = "L{\'a}szl{\'o} Bajnok and Klinika, {I. Belgy{\'o}gy{\'a}szati}",
year = "2013",
doi = "10.1556/OH.2013.29548",
language = "Hungarian",
volume = "154",
pages = "243--247",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Mire tanítanak a vérnyomáscsökkentokkel végzett újabb renoprotektív vizsgálatok?

AU - Bajnok, László

AU - Klinika, I. Belgyógyászati

PY - 2013

Y1 - 2013

N2 - From the evaluated ONTARGET, ALTITUDE, ACCOMPLISH, ROADMAP, and ACCORD-BP studies a conclusion can be drawn that though microalbuminuria/proteinuria is a strong epidemiological biomarker, in interventional studies it is not necessarily a reliable surrogate endpoint as actual renal function may change in an opposite way. Namely, some therapeutic measures improving microalbuminuria/proteinuria may actually worsen renal function. In case of procedures such as blood pressure lowering or measure of RAS blockade an optimum point on a J-curve may exist. Orv. Hetil., 2013, 154, 243-247.

AB - From the evaluated ONTARGET, ALTITUDE, ACCOMPLISH, ROADMAP, and ACCORD-BP studies a conclusion can be drawn that though microalbuminuria/proteinuria is a strong epidemiological biomarker, in interventional studies it is not necessarily a reliable surrogate endpoint as actual renal function may change in an opposite way. Namely, some therapeutic measures improving microalbuminuria/proteinuria may actually worsen renal function. In case of procedures such as blood pressure lowering or measure of RAS blockade an optimum point on a J-curve may exist. Orv. Hetil., 2013, 154, 243-247.

KW - blood pressure lowering

KW - J-curve

KW - proteinuria

KW - RAS blockade

KW - renoprotection

UR - http://www.scopus.com/inward/record.url?scp=84873652127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873652127&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29548

DO - 10.1556/OH.2013.29548

M3 - Article

VL - 154

SP - 243

EP - 247

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -